Please use this identifier to cite or link to this item: https://ahro.austin.org.au/austinjspui/handle/1/27386
Title: The intracellular domains of the EphB6 and EphA10 receptor tyrosine pseudokinases function as dynamic signaling hubs.
Austin Authors: Liang, Lung-Yu;Roy, Michael;Horne, Christopher;Sandow, Jarrod J;Surudoi, Minglyanna;Dagley, Laura F;Young, Samuel N;Dite, Toby;Babon, Jeffrey J;Janes, Peter W ;Patel, Onisha;Murphy, James M;Lucet, Isabelle S
Affiliation: Walter and Eliza Hall Institute of Medical Research, Parkville, Australia
Olivia Newton-John Cancer Wellness and Research Centre
Issue Date: 17-Sep-2021
Date: 2021-08-25
Publication information: The Biochemical Journal 2021; 478(17): 3351-3371
Abstract: EphB6 and EphA10 are two poorly characterised pseudokinase members of the Eph receptor family, which collectively serves as mediators of contact-dependent cell-cell communication to transmit extracellular cues into intracellular signals. As per their active counterparts, EphB6 and EphA10 deregulation is strongly linked to proliferative diseases. However, unlike active Eph receptors, whose catalytic activities are thought to initiate an intracellular signalling cascade, EphB6 and EphA10 are classified as catalytically-dead, raising the question of how non-catalytic functions contribute to Eph receptor signalling homeostasis. In this study, we have characterised the biochemical properties and topology of the EphB6 and EphA10 intracellular regions comprising the juxtamembrane region, pseudokinase and SAM domains. Using small-angle X-ray scattering and crosslinking-mass spectrometry, we observed high flexibility within their intracellular regions in solution and a propensity for interaction between the component domains. We identified tyrosines in the juxtamembrane region of EphB6 as EphB4 substrates, which can bind the SH2 domains of signalling effectors, including Abl, Src and Vav3, consistent with cellular roles in recruiting these proteins for downstream signaling. Furthermore, our finding that EphB6 and EphA10 can bind ATP and ATP-competitive small molecules raises the prospect that these pseudokinase domains could be pharmacologically-targeted to counter oncogenic signalling.
URI: https://ahro.austin.org.au/austinjspui/handle/1/27386
DOI: 10.1042/BCJ20210572
Journal: The Biochemical Journal
PubMed URL: 34431498
Type: Journal Article
Subjects: Eph Receptors
Kinase inhibitors
Molecular switches
Pseudokinases
molecular scaffolds
signalling
Appears in Collections:Journal articles

Show full item record

Page view(s)

30
checked on Dec 27, 2024

Google ScholarTM

Check


Items in AHRO are protected by copyright, with all rights reserved, unless otherwise indicated.